Clinical trial
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy : Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
NCT06029218 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy : Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 13, 2023
- Completion date
- October 1, 2031
- Enrollment
- 106 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chondrosarcoma, chordoma, ewing sarcoma, osteosarcoma